Intrauterine devices are a safe form of contraception in users with solid organ transplantation: A single‐center experience
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Stephanie I Amaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Stanford University, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Organ Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Patients who undergo organ transplantation are advised to use contraception for health optimization, yet limited data exists on safe contraceptive options for this population. This study investigates the infection risk of intrauterine devices (IUDs) in patients who have received a solid organ transplant by evaluating the incidence of pelvic inflammatory disease (PID). We performed a retrospective chart review of subjects with a solid organ transplant who used an IUD between the years of January 2007 to February 2021. We included subjects ages 22–55 years at the time of IUD placement. We abstracted demographic information, transplant type, IUD type, immunosuppressive medications, screening for sexually transmitted infections, and diagnosis of PID. We identified 29 subjects that met the inclusion criteria. Six subjects had a copper IUD (21%) and 23 had a levonorgestrel IUD (79%). The most common organ transplanted was a kidney ( n = 10) and liver ( n = 10) while five subjects had multiple organs transplanted. Twenty‐five (86.2%) subjects took immunosuppressive medications at the time of IUD insertion. Twenty‐four (82.8%) patients had their IUD placed after transplantation. The average time of IUD use was 2.5 years. . In our study of IUD use in patients with solid organ transplantation, no patients developed PID. IUDs are a safe contraceptive option for immunosuppressed transplant patients. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Stanford University, Palo Alto, California, USA.
- Department of Obstetrics and Gynecology, University of Kansas, Kansas City, Kansas, USA.
ORCID-Profile: Stephanie I Amaya
Zitieren
APA
Amaya, S. I., Wolff, S. F., Ross, M., & French, V. A. (2024). Intrauterine devices are a safe form of contraception in users with solid organ transplantation: A single‐center experience. Transplant Infectious Disease. https://doi.org/10.1111/tid.14220
Vancouver
Amaya SI, Wolff SF, Ross M, French VA. Intrauterine devices are a safe form of contraception in users with solid organ transplantation: A single‐center experience. Transplant Infectious Disease. 2024. doi:10.1111/tid.14220
BibTeX
@article{Amaya2024,
author = {Amaya, Stephanie I and Wolff, Sharon F and Ross, Meghan and French, Valerie A},
title = {Intrauterine devices are a safe form of contraception in users with solid organ transplantation: A single‐center experience},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14220}
}
EUVIMED